Herbert Smith Freehills advises Mitsui on strategic acquisition of a 10% interest in Russia's R-Pharm
Leading global law firm Herbert Smith Freehills has advised Mitsui & Co., Ltd. on its strategic acquisition of a 10% interest in JSC R-Pharm, one of the largest pharmaceutical companies in Russia.
The investment will help R-Pharm contribute to the Russian government's policy to produce more and higher quality drugs domestically, with Mitsui helping R-Pharm to enhance its manufacturing technology and using its networks to accelerate R-Pharm's licensing of new drugs from Japanese, European and American manufacturers.